MiMedx Group, Inc. (MDXG) Financial Statements
MiMedx Group, Inc. (MDXG) reported trailing twelve-month revenue of $355.2M (down 2.4% year on year) and net income of $6.2M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $44.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MDXGMiMedx Group, Inc.Follow MDXG — free
—
Price chart with a free account
- Market cap
- 569.9M
- P/E TTM
- 97.8
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.8 | 359.1 | 299.3 | 248.2 | 242.0 | 267.8 | 321.5 | 348.9 | 418.6 | 355.2 | |
| Gross profit | 4.4 | 322.7 | 256.2 | 208.9 | 202.4 | 219.5 | 266.8 | 288.8 | 345.6 | 280.1 | |
| Research & development | 3.0 | 15.8 | 11.1 | 11.7 | 9.9 | 12.7 | 12.7 | 12.3 | 15.1 | 15.4 | |
| Operating income | -9.8 | -3.9 | -21.2 | -45.4 | -7.1 | -14.7 | 37.1 | 58.9 | 63.9 | 8.8 | |
| Pre-tax income | -10.2 | -3.4 | -25.6 | -61.5 | -12.1 | -19.7 | 30.6 | 57.3 | 66.3 | 11.5 | |
| Income tax | 0.0 | 26.6 | -0.0 | -12.3 | 0.2 | 0.2 | -36.8 | 15.3 | 17.7 | 5.3 | |
| Net income | -10.2 | -30.0 | -25.6 | -49.3 | -10.3 | -30.2 | 58.2 | 42.4 | 48.6 | 6.2 | |
| Diluted EPS ($) | -0.14 | -0.28 | -0.24 | -0.77 | -0.15 | -0.33 | 0.37 | 0.28 | 0.32 | 0.04 | |
| Diluted shares (mn) | — | 105.6 | 106.9 | 108.3 | 110.4 | 112.9 | 146.0 | 149.0 | 149.7 | — |
USD millions · SEC XBRL
MiMedx Group, Inc. — questions
- What is MiMedx Group, Inc.'s revenue?
- $355.2M over the twelve months to 2026-06-30, down 2.4% year on year, from its 10-Q and 10-K filings.
- What is MiMedx Group, Inc.'s net income?
- $6.2M over the twelve months to 2026-06-30.
- What is MiMedx Group, Inc.'s free cash flow?
- $44.5M over the twelve months to 2026-06-30.
- What are MiMedx Group, Inc.'s diluted earnings per share?
- $0.04 over the twelve months to 2026-06-30.
Every figure on this page comes from MiMedx Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.